Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation

NCT03247413 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT03247413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03247413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation
Lead sponsor
Johns Hopkins University
Phase
Phase 4
Overall status
Terminated
Start date
September 1, 2019
Completion date
October 14, 2022
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuritis, radiofrequency ablation